Chancroid in Tlemcen (West Algeria): state of this STD in 1995. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Chancroid in Tlemcen (West Algeria): state of this STD in 1995.

Int Conf AIDS. 1996 Jul 7-12;11(1):137 (abstract no. Mo.C.1474). Unique Identifier : AIDSLINE MED/96921532
Boudghene-Stamboul IO; Merad-Boudia A; Stanbouli Department of Dermatology and Venereology, University; Hospital Of Tlemcen, Algeria. Fax: 213.7.20.25.51.

Abstract: Introduction: Absent for several decades, the chancroid reappeared in Algeria in 1988. In the unique department of Dermatology and Venereglogy of the county of Tlemcen (more than 700,000 inhabitants we wanted to know the state of this STD seven years after then report of the first cases. Methods: The file of the consulting patients were examined. We looked for the principal characteristics of this STD=age, sex, incubation period, place of the infecting contact, type of relation clinical presentation, evolution without and with treatment, other associated STD (Syphilis, HIV). Results: From August 1988 (1st case) to June 1995, 140 cases of chancroid were collected = 1988 =6, 1989=5, 1990= 7 cas, 1991 =18, 1992= 11, 1993= 33, 1994 = 48 and from january to june 1995 =12. The presentation is quite stereotyped it concerns males only, singles in most cases, having had sexual relations with prostitutes. The incubation period is short (less than 10 days, the characteristic ulceration present, very often, some adnepathies. The treatment by cotrimoxazole is efficient. There are no concomittant syphilis or HIV infection. Conclusions: The chancroid is the first cause of genital ulceration, in the world. Since 1991, it is the principal STD in our Department. It spreads within a male population, young singles associated with prostitutes. It is well installed in Algeria, and its role, although minor, in the transmission of the HIV infection, should not be neglected.
Keywords: *Chancroid/EPIDEMIOLOGYKWDchancroid/epidemiology
970130
M9715751

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .